Skip to content

Effect of Ibuprofen and Arginine gel on sensitivity after whitening: controlled clinical study

Desensitizing action of topical application of Ibuprofen and Arginine gel on post-whitening sensitivity: a randomized, double-blind, split-mouth clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
REBEC
Registry ID
RBR-8skkj7q
Enrollment
Unknown
Registered
2025-05-05
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dental sensitivity

Interventions

A controlled, randomized, double-blind clinical trial will be conducted to evaluate the efficacy of a desensitizing gel after dental whitening with a total of 30 people who meet the eligibility criter

Sponsors

União Educacional de Cascavel
Lead Sponsor
FGM Dental Group
Collaborator

Eligibility

Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Patients of both sexes; aged between 18 and 30 years; presence of all vital anterior teeth; never having undergone dental whitening; not having restored anterior teeth; not having central incisor teeth with color A2 or darker

Exclusion criteria

Exclusion criteria: Patients with missing front teeth; with caries lesions; presence of gingival recession; with any restorative or prosthetic treatments; history of dental hypersensitivity; dental discoloration due to Tetracycline or Fluorosis; who use continuous medications such as anti-inflammatories and analgesics; pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
It is expected to find a notable reduction in dentin sensitivity during and after dental whitening, improving the patient's experience of dental whitening

Secondary

MeasureTime frame
No secondary outcome

Countries

Brazil

Contacts

Public Contactsuelen dalagustinho

União Educacional de Cascavel

suelenkauana@icloud.com+55(45)991051230

Outcome results

None listed

Source: REBEC (via WHO ICTRP)